CoGenesys, launched by Human Genome Sciences co-founder Craig Rosen and his partner Steven Mayer, aims to develop new drugs that will interest big firms rather than create products to take to market. Rosen's move to the company is an example of the maturing of the biotech industry and of scientific entrepreneurs leaving product commercialization to return to the laboratories.

Related Summaries